Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Farid

Showing results (21-30 of 282) with videos related to

Pageof 29
Sort By:
Human Heredity|January 1, 1979
Polymorphic variants of the third component of complement in Graves' diseaseB Pepper, N R Farid
Clinical Chemistry|July 1, 1977
Assessment of a method for measuring serum thyroxine by radioimmunoassay, with use of polyethylene glycol precipitationN R Farid, C Kennedy
Molecular Genetics and Metabolism|April 3, 2004
Evolutionary divergence of thyrotropin receptor structureBjarne Knudsen, Nadir R Farid
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1984
Effect of triiodothyronine on the short-lived and concanavalin-A generated suppressor T-cell functionsC Balàzs, N R Farid
Journal of Endocrinological Investigation|March 9, 2002
Soluble CD4 concentrations predict relapse of post-partum thyroiditisC Balázs, N R Farid
Thyroid : Official Journal of the American Thyroid Association|March 28, 2002
MHC class II expression in Graves' diseaseCsaba Balázs, Nadir R Farid
Lancet (London, England)|June 24, 1972
Cerebrovascular disease and hyperlipoproteinaemiaN R Farid, J Anderson
Lancet (London, England)|July 14, 1973
Immunoglobulins and complement in diabetes mellitusN R Farid, J Anderson
Acta Medica Hungarica|January 1, 1991
Soluble interleukin-2 receptor in sera of patients with Graves' diseaseC Balázs, N R Farid
Journal of Autoimmunity|August 1, 1991
Soluble interleukin-2 receptor in sera of patients with Graves' diseaseC Balazs, N R Farid
Pageof 29

Showing results (21-30 of 282) with videos related to

Sort By:
Pageof 29
Human Heredity|January 1, 1979
Polymorphic variants of the third component of complement in Graves' diseaseB Pepper, N R Farid
Clinical Chemistry|July 1, 1977
Assessment of a method for measuring serum thyroxine by radioimmunoassay, with use of polyethylene glycol precipitationN R Farid, C Kennedy
Molecular Genetics and Metabolism|April 3, 2004
Evolutionary divergence of thyrotropin receptor structureBjarne Knudsen, Nadir R Farid
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1984
Effect of triiodothyronine on the short-lived and concanavalin-A generated suppressor T-cell functionsC Balàzs, N R Farid
Journal of Endocrinological Investigation|March 9, 2002
Soluble CD4 concentrations predict relapse of post-partum thyroiditisC Balázs, N R Farid
Thyroid : Official Journal of the American Thyroid Association|March 28, 2002
MHC class II expression in Graves' diseaseCsaba Balázs, Nadir R Farid
Lancet (London, England)|June 24, 1972
Cerebrovascular disease and hyperlipoproteinaemiaN R Farid, J Anderson
Lancet (London, England)|July 14, 1973
Immunoglobulins and complement in diabetes mellitusN R Farid, J Anderson
Acta Medica Hungarica|January 1, 1991
Soluble interleukin-2 receptor in sera of patients with Graves' diseaseC Balázs, N R Farid
Journal of Autoimmunity|August 1, 1991
Soluble interleukin-2 receptor in sera of patients with Graves' diseaseC Balazs, N R Farid
Pageof 29